Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting (Tables)

v3.23.1
Segment Reporting (Tables)
3 Months Ended
Feb. 28, 2023
Segment Reporting [Abstract]  
Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, and Interest Expense and Assets by Segment

The following table shows, by segment: net revenue, cost of sales, depreciation and amortization, operating profit, and interest expense for the three months ended February 28, 2023 and 2022:

 

 

 

For the three months ended February 28,

 

 

 

2023

 

 

2022

 

Net revenue:

 

 

 

 

 

 

Umbilical cord blood and cord tissue stem cell service

 

$

7,561,518

 

 

$

7,157,486

 

PrepaCyte CB

 

 

32,200

 

 

 

18,200

 

Public cord blood banking

 

 

230,697

 

 

 

82,845

 

Total net revenue

 

$

7,824,415

 

 

$

7,258,531

 

Cost of sales:

 

 

 

 

 

 

Umbilical cord blood and cord tissue stem cell service

 

$

1,687,250

 

 

$

1,714,672

 

PrepaCyte CB

 

 

17,122

 

 

 

30,658

 

Public cord blood banking

 

 

362,992

 

 

 

357,872

 

Total cost of sales

 

$

2,067,364

 

 

$

2,103,202

 

Operating profit:

 

 

 

 

 

 

Umbilical cord blood and cord tissue stem cell service

 

$

1,807,693

 

 

$

1,765,213

 

PrepaCyte CB

 

 

8,133

 

 

 

(19,403

)

Public cord blood banking

 

 

(132,655

)

 

 

(275,388

)

Total operating profit

 

$

1,683,171

 

 

$

1,470,422

 

Depreciation and amortization:

 

 

 

 

 

 

Umbilical cord blood and cord tissue stem cell service

 

$

273,539

 

 

$

270,862

 

PrepaCyte CB

 

 

6,945

 

 

 

6,944

 

Public cord blood banking

 

 

360

 

 

 

360

 

Total depreciation and amortization

 

$

280,844

 

 

$

278,166

 

Interest expense:

 

 

 

 

 

 

Umbilical cord blood and cord tissue stem cell service

 

$

466,231

 

 

$

306,095

 

PrepaCyte CB

 

 

 

 

 

 

Public cord blood banking

 

 

 

 

 

 

Total interest expense

 

$

466,231

 

 

$

306,095

 

 

 

 

 

 

 

 

 

The following table shows the assets by segment as of February 28, 2023 and November 30, 2022:

 

 

As of

 

 

As of

 

 

 

February 28, 2023

 

 

November 30, 2022

 

Assets:

 

 

 

 

 

 

Umbilical cord blood and cord tissue stem cell
   service

 

$

56,298,385

 

 

$

54,849,697

 

PrepaCyte CB

 

 

140,439

 

 

 

176,546

 

Public cord blood banking

 

 

9,695,211

 

 

 

9,861,811

 

Total assets

 

$

66,134,035

 

 

$

64,888,054